Article Data

  • Views 722
  • Dowloads 123

Editorial

Open Access Special Issue

Complementary Elements to the Pathogenesis, Early Detection and Second Line Antihormonal Therapy of Prostate Cancer

  • Tamás Kullmann1,*,

1Department of Oncoradiology, Petz Aladár Hospital, 9024 Győr, Hungary

DOI: 10.31083/j.jomh1807155 Vol.18,Issue 7,July 2022 pp.1-2

Published: 31 July 2022

(This article belongs to the Special Issue Therapy and prognosis of metastatic prostate cancer)

*Corresponding Author(s): Tamás Kullmann E-mail: kullmanndoki@hotmail.com

Cite and Share

Tamás Kullmann. Complementary Elements to the Pathogenesis, Early Detection and Second Line Antihormonal Therapy of Prostate Cancer. Journal of Men's Health. 2022. 18(7);1-2.

References

[1] Sun X, Kour BD, Wang X, Hu X, Wang Y, Sugunakar VJ. In-sights into association between urolithiasis and prostate cancer. Journal of Men’s Health. 2021; 17: 52–61.

[2] Datta D, Aftabuddin M, Kundu R, Baid M, Das SK, Sarkar S, et al. A comprehensive mechanistic basis of prostate cancer ad-vancement & its personalized implementation-bridging the gap: present state and future prospect. Journal of Men’s Health. 2021; 17: 18–35.

[3] Lewis-Thames MW, Khan S, Hicks V, Drake BF. Predictors of annual prostate-specific antigen (PSA) screening among black men: results from an urban community-based prostate cancer screening program. Journal of Men’s Health. 2021; 17: 78–83.

[4] Porav-Hodade D, Balan D, Gherasim R, Vida OA, Todea-Moga C, Voidazan S, et al. Decrease in prostate cancer detection during COVID-19 pandemic. Journal of Men’s Health. 2021; 17: 151–155.

[5] Alkan A, Güç ZG, Gürbüz M, Özgün G, Değirmencioğlu S, Doğan M, et al. Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate can-cer in geriatric (≥75) patients. Journal of Men’s Health. 2021; 17: 128–134.

[6] Yang X, Shan J, Zhang Q, Yuan Z, Xu H, Liu Z, et al. The diag-nostic value of a new formula combining age and prostate vol-ume in prostate cancer. Journal of Men’s Health. 2022; 18: 29.

[7] András S, Károly K, Adél A, Noémi K, Zsolt S, Tamás K. A single centre pilot experience with 18F-JK-PSMA-7 PET-CT in the staging of prostate cancer. Journal of Men’s Health. 2022; 18: 45.

[8] Tamás K, Károly K, Adél A, Noémi K, Ágnes H, Zsolt S. Op-timisation of second line antihormonal treatment for castration resistant metastatic prostate cancer. Journal of Men’s Health. 2022; 18: 93.

[9] Khader AA, Nsour E, Edwan TA. Prostatic signet-ring adeno-carcinoma: a case report. Journal of Men’s Health. 2022; 18: 90.

[10] Kullmann T, András S, Noémi K, Zsolt S. Neuroendocrine can-cer of the prostate. Two case reports. Journal of Men’s Health. 2022; 18: 065.

[11] Fang H, He L, He H, Wang X, Wang Y, Ge H, et al. The 100 most-cited articles in castration-resistant prostate cancer: a bib-liometric analysis. Journal of Men’s Health. 2022; 18: 3.

[12] Hurst R, Meader E, Gihawi A, Rallapalli G, Clark J, Kay GL, et al. Microbiomes of Urine and the Prostate are Linked to Hu-man Prostate Cancer Risk Groups. European Urology Oncology. 2022. (in press)


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top